Skip to main content
Qiagen, HTG Molecular announce 2nd development program

A second development program has been launched by Qiagen and HTG Molecular Diagnostics under a master assay development, commercialization and manufacturing deal that was announced last year. The program will include the development of gene expression profiling assays using HTG EdgeSeq technology to support the therapeutic development and commercialization programs of an unnamed pharmaceutical firm.

Full Story: